After 1 day
+6.08%$27.15 → $28.80
Aug 04, 2026 → Aug 05, 2026
Acadia Pharmaceuticals Inc.
/ ACADNMSWhat is ACAD stock?
ACAD is the U.S. stock ticker for Acadia Pharmaceuticals Inc..
As of 2026-09-13: price $27.83; market cap $4.8B; latest earnings 2026-08-04; 12 recent 13F changes.
$27.83+0.32%
Yahoo Finance ↗·Updated 09/13/2026, 08:19 PM UTC
- Current price
- $27.83
- Market cap
- $4.8B
- Latest earnings date
- Aug 04, 2026
- Data status
- Current
Yahoo Finance
Polygon.io
Nasdaq
Price change after earnings
After 7 days
+8.32%$27.15 → $29.41
Aug 04, 2026 → Aug 11, 2026
After 30 days
+2.62%$27.15 → $27.86
Aug 04, 2026 → Sep 03, 2026
Before-market or after-market timing is unavailable.
Reported date confirmed
Recent insider transactions
| Date | Trader / role | Type | Shares | Average price | Transaction value | Source |
|---|---|---|---|---|---|---|
| Aug 06, 2026 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sold | 5,000 | $29.00 | $145K | SEC ↗ |
| Aug 06, 2026 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sold | 9,292 | $29.34 | $272.6K | SEC ↗ |
| Aug 05, 2026 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sold | 5,849 | $29.00 | $169.64K | SEC ↗ |
| Jul 30, 2026 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Sold | 16,508 | $26.13 | $431.35K | SEC ↗ |
| Jul 30, 2026 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Sold | 50 | $26.17 | $1.31K | SEC ↗ |
| Jun 26, 2026 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sold | 11,421 | $26.08 | $297.91K | SEC ↗ |
| May 26, 2026 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sold | 5,401 | $21.18 | $114.39K | SEC ↗ |
| May 04, 2026 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sold | 1,332 | $21.79 | $29.02K | SEC ↗ |
| May 04, 2026 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sold | 3,506 | $21.79 | $76.4K | SEC ↗ |
| Apr 07, 2026 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sold | 2,709 | $22.20 | $60.14K | SEC ↗ |
| Apr 07, 2026 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sold | 1,030 | $22.20 | $22.87K | SEC ↗ |
Schneyer Mark C.Sold
EVP, CHIEF FINANCIAL OFFICER
5,000 · $29.00 · $145K
Aug 06, 2026SEC Form 4 ↗
Schneyer Mark C.Sold
EVP, CHIEF FINANCIAL OFFICER
9,292 · $29.34 · $272.6K
Aug 06, 2026SEC Form 4 ↗
Schneyer Mark C.Sold
EVP, CHIEF FINANCIAL OFFICER
5,849 · $29.00 · $169.64K
Aug 05, 2026SEC Form 4 ↗
EVP, Head of Research & Dev
16,508 · $26.13 · $431.35K
Jul 30, 2026SEC Form 4 ↗
EVP, Head of Research & Dev
50 · $26.17 · $1.31K
Jul 30, 2026SEC Form 4 ↗
Kihara JamesSold
PRINCIPAL ACCOUNTING OFFICER
11,421 · $26.08 · $297.91K
Jun 26, 2026SEC Form 4 ↗
Kihara JamesSold
PRINCIPAL ACCOUNTING OFFICER
5,401 · $21.18 · $114.39K
May 26, 2026SEC Form 4 ↗
Kihara JamesSold
PRINCIPAL ACCOUNTING OFFICER
1,332 · $21.79 · $29.02K
May 04, 2026SEC Form 4 ↗
Schneyer Mark C.Sold
EVP, CHIEF FINANCIAL OFFICER
3,506 · $21.79 · $76.4K
May 04, 2026SEC Form 4 ↗
Schneyer Mark C.Sold
EVP, CHIEF FINANCIAL OFFICER
2,709 · $22.20 · $60.14K
Apr 07, 2026SEC Form 4 ↗
Kihara JamesSold
PRINCIPAL ACCOUNTING OFFICER
1,030 · $22.20 · $22.87K
Apr 07, 2026SEC Form 4 ↗
Updated: 08/08/2026, 04:35 AM UTC
13F institutional changes
| Quarter | Institution | Type | Shares held | Share change | Value change | Source |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | BlackRock, Inc. | Added | 22,515,173 | +964,252 | +$89.91M | SEC 13F ↗ |
| Jun 30, 2026 | State Street Corp | Added | 9,076,212 | +743,441 | +$44.14M | SEC 13F ↗ |
| Jun 30, 2026 | Vanguard Portfolio Management LLC | Added | 8,838,450 | +166,805 | +$30.58M | SEC 13F ↗ |
| Jun 30, 2026 | Vanguard Capital Management LLC | Added | 5,763,750 | +102,350 | +$19.8M | SEC 13F ↗ |
| Jun 30, 2026 | Geode Capital Management, LLC | Reduced | 3,358,129 | -106,560 | +$7.84M | SEC 13F ↗ |
| Mar 31, 2026 | Dimensional Fund Advisors LP | Added | 3,155,160 | +233,716 | +$5.2M | SEC 13F ↗ |
| Mar 31, 2026 | Point72 Asset Management, L.P. | Reduced | 2,605,316 | -773,823 | -$17.23M | SEC 13F ↗ |
| Mar 31, 2026 | Norges Bank | Sold out | 1,507,527 | — | — | SEC 13F ↗ |
| Mar 31, 2026 | Renaissance Technologies LLC | Added | 1,724,196 | +191,577 | +$4.26M | SEC 13F ↗ |
| Mar 31, 2026 | Goldman Sachs Group Inc. | Reduced | 1,557,804 | -12,563 | -$279.65K | SEC 13F ↗ |
| Mar 31, 2026 | Bank of America Corp. | Added | 1,553,770 | +332,253 | +$7.4M | SEC 13F ↗ |
| Mar 31, 2026 | Northern Trust Corp | Added | 1,272,611 | +37,066 | +$825.1K | SEC 13F ↗ |
BlackRock, Inc.Added
- Quarter
- Jun 30, 2026
- Shares held
- 22,515,173
- Share change
- +964,252
- Value change
- +$89.91M
State Street CorpAdded
- Quarter
- Jun 30, 2026
- Shares held
- 9,076,212
- Share change
- +743,441
- Value change
- +$44.14M
- Quarter
- Jun 30, 2026
- Shares held
- 8,838,450
- Share change
- +166,805
- Value change
- +$30.58M
- Quarter
- Jun 30, 2026
- Shares held
- 5,763,750
- Share change
- +102,350
- Value change
- +$19.8M
- Quarter
- Jun 30, 2026
- Shares held
- 3,358,129
- Share change
- -106,560
- Value change
- +$7.84M
- Quarter
- Mar 31, 2026
- Shares held
- 3,155,160
- Share change
- +233,716
- Value change
- +$5.2M
- Quarter
- Mar 31, 2026
- Shares held
- 2,605,316
- Share change
- -773,823
- Value change
- -$17.23M
Norges BankSold out
- Quarter
- Mar 31, 2026
- Shares held
- 1,507,527
- Share change
- —
- Value change
- —
- Quarter
- Mar 31, 2026
- Shares held
- 1,724,196
- Share change
- +191,577
- Value change
- +$4.26M
Goldman Sachs Group Inc.Reduced
- Quarter
- Mar 31, 2026
- Shares held
- 1,557,804
- Share change
- -12,563
- Value change
- -$279.65K
- Quarter
- Mar 31, 2026
- Shares held
- 1,553,770
- Share change
- +332,253
- Value change
- +$7.4M
Northern Trust CorpAdded
- Quarter
- Mar 31, 2026
- Shares held
- 1,272,611
- Share change
- +37,066
- Value change
- +$825.1K
Share counts are derived from reported value divided by the filing price and are rounded for display.
Key people timeline
- Catherine Owen Adams
Acadia delivered an outstanding second quarter, highlighted by strong commercial execution across both DAYBUE and NUPLAZID, resulting in total revenue growth of 17% year-over-year on an adjusted basis
Acadia Pharmaceuticals Inc. (ACAD) - Catherine Owen Adams
Acadia delivered a solid first quarter of 2026 with total revenues of $268 million, driven by a strong start from DAYBUE, which generated sales of $101 million
Acadia Pharmaceuticals Inc. (ACAD)
Related data
Data sources and methodology
Prices use Yahoo Finance, earnings dates use Nasdaq, and company reference data prefers Polygon.io. When Polygon market cap is unavailable, the page derives it from the latest SEC shares outstanding multiplied by the Yahoo price. Insider and institutional records link to SEC EDGAR, and missing values are never invented.
Updated: 09/13/2026, 08:19 PM UTC
Collection, calculation and correction policy- Yahoo Finance
- 09/13/2026, 08:19 PM UTC
- Polygon.io
- 09/13/2026, 08:15 PM UTC
- Nasdaq earnings history
- 08/04/2026, 10:12 PM UTC
- SEC Form 4
- 08/08/2026, 04:35 AM UTC
- SEC 13F
- 08/07/2026, 05:05 PM UTC
- Statements / public records
- 08/04/2026, 08:20 PM UTC